Mallinckrodt Pharmaceuticals Ireland Limitedcollege Business Technology Parkcruiserath Roadblanchardstown D15 T Pma Numberp860003 Supplement Numbers107 Date Received04 27 2022 Decision Date05 25 2022 Product Code Lnr Advisory Committee Gastroenterology Urology Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No

FDA Filings

This page includes the latest FDA filings for Mallinckrodt Pharmaceuticals Ireland Limitedcollege Business Technology Parkcruiserath Roadblanchardstown D15 T Pma Numberp860003 Supplement Numbers107 Date Received04 27 2022 Decision Date05 25 2022 Product Code Lnr Advisory Committee Gastroenterology Urology Supplement Type30 Day Notice Supplement Reason Process Change Manufacturer Sterilizer Packager Supplier Expedited Review Granted No. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device
Company
DeviceDate
Mallinckrodt Pharmaceuticals Ireland Limitedcollege Business & Technology Parkcruiserath Roadblanchardstown D15 T PMA NumberP860003 Supplement NumberS107 Date Received04/27/2022 Decision Date05/25/2022 Product Code LNR  Advisory Committee Gastroenterology/Urology Supplement Type30-day Notice Supplement Reason Process Change - Manufacturer/sterilizer/packager/supplier Expedited Review Granted? No
THERAKOS CELLEX Photopheresis System (CELLEX), THERAKOS CELLEX Photopheresis Procedural Kit (CLXUSA and CLXECP),THERAKOS2022-05-25

Related Finance Registrations

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.